MGX logo
MGX

Metagenomi Therapeutics Inc

Biotechnology

Metagenomi Therapeutics Inc (MGX) Earnings

Last reported
May 19, 2026
EPS estimate
-$0.53
EPS actual
Revenue est.
$6.0M
Revenue actual